Novavax Submits a Request to The WHO and Carnival Announces Cruise Openings
Novavax is a healthcare company that works in the biotech industry. They have a market cap of $19.165 billion, and they focus on developing vaccines for diseases. The stock saw a major boost at the start of the pandemic as they were in the running for the COVID-19 vaccine.
On Thursday, Novavax announced their submission to the WHO for an emergency use listing for their COVID-19 vaccine. This marks a major step for them, and it allows for their vaccine to be exported to multiple countries. Access to the vaccine in the developing world has been low, so this vaccine could be provided to those countries and boost the global vaccination rate. Due to this news, Novavax closed the day at $257.30, up 10.90%.
Carnival is a Miami-based leisure company that operates hundreds of cruise ships all around the world. They have a market cap of $28.59 billion, but they’ve been struggling massively as the pandemic led to the suspension of cruises throughout the world.
On Thursday, Carnival announced that they are on track to have 50% of their fleet sailing by October, and 65% by the end of 2021. This is a good development for Carnival as people felt the Delta variant could derail their recovery, which looks to be wrong now. Many Americans are excited to leave their houses and go on cruises now, so leisure companies look to grow even more. Carnival closed the day up 4.57% to $24.69.
I am not a financial advisor and my comments should never be taken as financial advice. Investments come with risk, so always do your research and analysis beforehand.